Acute promyelocytic leukemia: As a cause of intracoronary drug-eluting-stent thrombosis

Texas Heart Institute Journal

Volumn 39, Issue 3, 2012, Pages 416-419

  Sargsyan, Zaven ^d   Higgins, Christopher ^a   Alexandrescu, Sanda ^c   Ott, David A ^b   Jain, Surendra K ^a  

^a Departments of Cardiology   (United States)

^b Cardiovascular Surgery   (United States)

^c ST LUKE S EPISCOPAL HOSPITAL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Acute; Control; Coronary thrombosis etiology prevention; Drug eluting; Hypercoagulability; Hyperhomocysteinemia; Leukemia; Mycobacterium fortuitum; Myeloid; Promyelocytic; Stents; Stents adverse effects; Stents thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; HEART ENZYME; PRASUGREL;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL EVALUATION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY HEMODYNAMICS; CORONARY STENT; DIABETES MELLITUS; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG ELUTING STENT; ELECTROCARDIOGRAPHY MONITORING; GENE TRANSLOCATION; HEART CATHETERIZATION; HUMAN; HUMAN TISSUE; HYPERTENSION; LEUKOCYTE COUNT; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PANCYTOPENIA; PARTIAL THROMBOPLASTIN TIME; PREOPERATIVE PERIOD; PROMYELOCYTIC LEUKEMIA; PROTHROMBIN TIME; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; THORAX PAIN; THROMBOCYTE COUNT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON, CORONARY; ANTERIOR WALL MYOCARDIAL INFARCTION; BIOPSY; BONE MARROW EXAMINATION; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSTHESIS DESIGN; RECURRENCE;

EID: 84864108642     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001;103(15):1967-71.
2. Mueller C, Roskamm H, Neumann FJ, Hunziker P, Marsch S, Perruchoud A, Buettner HJ. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents. J Am Coll Cardiol 2003; 41(6):969-73.
3. Wiviott SD, Braunwald E, McCabe CH, Horvath I, Keltai M, Herrman JP, et al. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITONTIMI 38 trial: a subanalysis of a randomised trial. Lancet 2008;371(9621):1353-63.
4. Dixit A, Kannan M, Mahapatra M, Choudhry VP, Saxena R. Roles of protein C, protein S, and antithrombin III in acute leukemia. Am J Hematol 2006;81(3):171-4.
5. Chang H, Lin TL, Ho WJ, Hsu LA. Acute myeloid leukemia associated with acute myocardial infarction and dural sinus thrombosis: the possible role of leukemia-related hyperhomocysteinemia. J Chin Med Assoc 2008;71(8):416-20.
6. Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, et al. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999;131(5):331-9.
7. Eshtehardi P, Eslami M, Moayed DA. Simultaneous subacute coronary drug-eluting stent thrombosis in two different vessels of a patient with factor V Leiden mutation. J Cardiovasc Med (Hagerstown) 2008;9(4):410-3.
8. Muir DF, Stevens A, Napier-Hemy RO, Fath-Ordoubadi F, Curzen N. Recurrent stent thrombosis associated with lupus anticoagulant due to renal cell carcinoma. Int J Cardiovasc Intervent 2003;5(1):44-6.
9. Gross CM, Posch MG, Geier C, Olthoff H, Kramer J, Dechend R, et al. Subacute coronary stent thrombosis in cancer patients. J Am Coll Cardiol 2008;51(12):1232-3.
10. Altwegg SC, Altwegg LA, Maier W. Intracoronary thrombus with tissue factor expression heralding acute promyelocytic leukaemia. Eur Heart J 2007;28(22):2731.
11. van Werkum JW, Heestermans AA, Zomer AC, Kelder JC, Suttorp MJ, Rensing BJ, et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol 2009;53(16):1399-409.
12. Krone RJ. Managing coronary artery disease in the cancer patient. Prog Cardiovasc Dis 2010;53(2):149-56.
13. Kaleem Z, Watson MS, Zutter MM, Blinder MA, Hess JL. Acute promyelocytic leukemia with additional chromosomal abnormalities and absence of Auer rods. Am J Clin Pathol 1999;112(1):113-8.
14. Olalla J, Pombo M, Aguado JM, Rodriguez E, Palenque E, Costa JR, Rioperez E. Mycobacterium fortuitum complex endocarditis- case report and literature review. Clin Microbiol Infect 2002;8(2):125-9.
15. Collison SP, Trehan N. Native double-valve endocarditis by Mycobacterium fortuitum following percutaneous coronary intervention. J Heart Valve Dis 2006;15(6):836-8.
16. Galil K, Thurer R, Glatter K, Barlam T. Disseminated Mycobacterium chelonae infection resulting in endocarditis. Clin Infect Dis 1996;23(6):1322-3.
17. Singh M, Bofinger A, Cave G, Boyle P. Mycobacterium fortuitum endocarditis in a patient with chronic renal failure on hemodialysis. Pathology 1992;24(3):197-200.
18. Spell DW, Szurgot JG, Greer RW, Brown JW 3rd. Native valve endocarditis due to Mycobacterium fortuitum biovar fortuitum: case report and review. Clin Infect Dis 2000;30(3):605- 6.
19. Kuruvila MT, Mathews P, Jesudason M, Ganesh A. Mycobacterium fortuitum endocarditis and meningitis after balloon mitral valvotomy. J Assoc Physicians India 1999;47(10): 1022-3.
20. Redelman-Sidi G, Sepkowitz KA. Rapidly growing mycobacteria infection in patients with cancer. Clin Infect Dis 2010;51 (4):422-34.
21. Raad II, Vartivarian S, Khan A, Bodey GP. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis 1991;13(6):1120-5.